Differences between cytokine effects in the microcirculation of the rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 3 40-3, 1996, Pages

  Baudry, Nathalie ^b   Rasetti, Christine ^b   Vicaut, Eric ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b NONE

Author keywords

interleukin 6; interleukin 1; sepsis; thromboxane; tumor necrosis factor; vascular reactivity

Indexed keywords

7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; POTASSIUM CHLORIDE; RECOMBINANT TUMOR NECROSIS FACTOR; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; TUMOR NECROSIS FACTOR;

ARTERY DIAMETER; ARTICLE; BLOOD VESSEL REACTIVITY; BLOOD VESSEL TONE; CARDIOVASCULAR EFFECT; CREMASTER MUSCLE; GRAM NEGATIVE INFECTION; MALE; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SEPSIS;

EID: 0029799081     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.3.h1186     Document Type: Article

References (37)

1. Alexander, H. R., G. M. Doherty, D. J. Venzon, M. J. Merino, D. L. Fraker, and J. A. Norton. Recombinant interleukin-1 receptor antagonist (IL1ra): effective therapy against gram-negative sepsis in rats. Surgery St. Louis 112: 188-194, 1992.
2. Baez, S. An open cremaster preparation for the study of blood vessels by in vivo microscopy. Microvasc. Res. 5: 384-394, 1973.
3. Baudry, N., and E. Vicaut. Role of nitric oxide in effects of tumor necrosis factor-α on microcirculation in rat. J. Appl. Physiol. 75: 2392-2399, 1993.
4. Bauss, F., W. Droge, and D. N. Männel. Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55: 1622-1625, 1987.
5. Beasley, D., R. A. Cohen, and N. G. Levinsky. Interteukin 1 inhibits contraction of vascular smooth muscle. J. Clin. Invest. 83: 331-335, 1989.
6. Beasley, D., J. H. Schwartz, and B. M. Brenner. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat smooth muscle cells. J. Clin. Invest. 87: 602-608, 1991.
7. Bernard, C., and A. Tedgui. Cytokine network and the vessel wall. Insights into septic shock pathogenesis. Eur. Cytokine Netw. 3: 19-33, 1992.
8. Beutler, B. A., I. W. Milsark, and A. Cerami. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo. J. Immunol. 135: 3972-3977, 1985.
9. Beutler, B. A., I. W. Milsark, and A. C. Cerami. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science Wash. DC 229: 869-871, 1985.
10. Endo, S., K. Inada, Y. Inoue, Y. Kuwata, M. Suzuki, H. Yamashita, S. Hoshi, and M. Yoshida. Two types of septic shock classified by the plasma levels of cytokines and endotoxin. Circ. Shock 38: 264-274, 1992.
11. Fong, Y., and S. F. Lowry. Tumor necrosis factor in the pathophysiology of injection and sepsis. Clin. Immunol. Immunopathol. 55: 157-170, 1990.
12. French, J. F., L. E. Lambert, and R. C. Dage. Nitric oxide synthase inhibitors inhibit interleukin-1β-induced depression of vascular smooth muscle. J. Pharmacol. Exp. Ther. 259: 260-264, 1991.
13. Hess, M., A. Hastillo, and L. Greenfield. Spectrum of cardiovascular function during gram-negative sepsis. Prog. Cardiovasc. Dis. 23: 279-297, 1981.
14. Hesse, D. G., K. J. Tracey, Y. Fong, K. R. Manogue, M. A. Palladino, A. Cerami, T. Shires, and S. F. Lowry. Cytokine appearance in human endotoxemia and primate bacteremia. Surg. Gynecol. Obstet. 166: 147-153, 1988.
15. Intaglietta, M., and W. R. Tompkins. Microvascular measurement by video image shearing and splitting (Abstract). Microvase. Res. 5: 312, 1973.
16. Kilbourn, R. G., and O. W. Griffith. Overproduction of nitric oxide in cvtokine-mediated and septic shock. J. Natl. Cancer Inst. 84: 827-831, 1992.
17. G-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc. Natl. Acad. Sci. USA. 87: 3629-3632, 1990.
18. McKenna, T. M., and W. A. W. Titius. Molecular and Cellular Mechanisms of Septic Shock. New York: Liss, 1989, p. 279-303.
19. Michie, H. R., K. R. Manogue, D. R. Spriggs, A. Revhaug, S. O'Dwyer, C. A. Dinarello, A. Cerami, S. M. Wolff, and D. W. Wilmore. Detection of circulating tumor necrosis factor after endotoxin administration. N. Engl. J. Med. 318: 1481-1486, 1988.
20. Ohkawa, F., U. Ikeda, K. Kawasaki, E. Kusano, M. Igarashi, and K. Shimada. Inhibitory effect of interleukin-6 on vascular smooth muscle contraction. Am. J. Physiol. 266 (Heart Circ. Physiol 35): H898-H902, 1994.
21. Okusawa, S., J. A. Gelfand, T. Ikejima, R. J. Connolly, and C. A. Dinarello. Interleukin 1 induces a shock-like state in rabbits-synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. J. Clin. Invest. 81: 1162-1172, 1988.
22. Parker, J. L., and H. R. Adams. Selective inhibition of endothelium-dependent vasodilator capacity by Escherichia coli endotoxemia. Circ. Res. 72: 539-551, 1993.
23. Pastor, C., B. Teisseire, E. Vicaut, and D. Payen. Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit. Care Med. 22: 465-469, 1994.
24. Philip, I., C. Bernard, D. Payen, and A. Tedgui. Depression of contratile response in rabbit carotid artery by tumor necrosis factor (Abstract). Circulation 80, Suppl. II: 126, 1989.
25. Rasetti, C., and E. Vicaut. Short exposure to endotoxin increases the constriction induced by angiotensin II in rat aorta. J. Appl. Physioi. 79: 2094-2100, 1995.
26. Remick, D. G., R. G. Kunkel, J. W. Larrick, and S. L. Kunkel. Acute in vivo effects of human recombinant tumor necrosis factor. Lab. Invest. 56: 583-590, 1987.
27. Shibata, M., C. W. Leffler, and D. W. Busija. Recombinant human interleukin 1α dilates pial arterioles and increases cerebrospinal fluid prostanoids in piglets. Am. J. Physiol. 259 (Heart Circ. Physiol. 28): H1486-H1491, 1990.
28. Starnes, H. F., M. K. Pearce, A. Tewari, J. H. Yim, J.-C. Zou, and J. S. Abrams. Anti-IL-6 monoclonal antibodies protect against lethal Escherichia coli infection and lethal tumor necrosis factor-α challenge in mice. J. Immunol. 145: 4185-4194, 1990.
29. Szabo, C., C.-C. Wu, S. S. Gross, C. Thiemermann, and J. R. Vane. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo. Eur. J. Pharmacol. 250: 157-160, 1993.
30. Tracey, K. J., B. A. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, R. J. Hariri, T. J. Fahey III, A. Zentella, J. D. Albert, G. T. Shires, and A. Cerami. Shock and tissue injury induced by recombinant human cachectin. Science Wash. DC 234: 470-474, 1986.
31. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature Lond. 330: 662-664, 1987.
32. Vicaut, E., and X. Hou. Evidence of collateral circulation in rat cremaster muscle. Microvasc. Res. 36: 187-190, 1988.
33. Vicaut, E., and X. Hou. Arteriolar constriction and local renin-angiotensin system in rat microcirculation. Hypertension Dallas 21: 491-497, 1993.
34. Vicaut, E., X. Hou, D. Payen, A. Bousseau, and A. Tedgui. Acute effects of tumor necrosis factor on the microcireulation in rat cremaster muscle. J. Clin. Invest. 87: 1537-1540, 1991.
35. Winer, B. J. Statistical Principles in Experimental Design. New York: McGraw-Hill, 1971.
36. Yoshida, K., T. Okamura, and N. Toda. Potentiation by hypoxia of contractions caused by angiotensin II in dog and monkey cerebral arteries. Stroke 24: 421-426, 1993.
37. Zweifach, B. W., and H. H. Lipowsky. Pressure-flow relations in blood and lymph microcireulation. In: Handbook of Physiology The Cardiovascular System. Microcirculation. Bethesda, MD: Am. Physiol. Soc., 1984, sect. 2, vol. IV, pt. 1, chapt. 7, p. 251-307